Zewei Y. Mao

Yunnan Key Laboratory Of Dai And Yi Medicines
Kunming, 650500, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Correction: New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways.

Correction: New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways.

Journal: Molecular diversity

Published: August 07, 2026

Vasicine-Based Synergistic Antifungal Agents against FLC-Resistant Candida albicans Targeting Ras/cAMP/PKA Pathway.

Vasicine-Based Synergistic Antifungal Agents against FLC-Resistant Candida albicans Targeting Ras/cAMP/PKA Pathway.

Journal: ACS medicinal chemistry letters

Published: April 07, 2026

Exploration of novel costunolide derivatives bearing indole/indoline as anti-ulcerative colitis agents by targeting JAK2-STAT3 pathways.

Exploration of novel costunolide derivatives bearing indole/indoline as anti-ulcerative colitis agents by targeting JAK2-STAT3 pathways.

Journal: Bioorganic chemistry

Published: January 20, 2026

Vasicine derivatives as potent MAPK inhibitors for psoriasis treatment.

Vasicine derivatives as potent MAPK inhibitors for psoriasis treatment.

Journal: Molecular diversity

Published: September 05, 2025

Glycolysis-mediated energy metabolism mechanisms: Synergistic antifungal activity of (±)-methylagrimonolide against drug-resistant Candida albicans.

Glycolysis-mediated energy metabolism mechanisms: Synergistic antifungal activity of (±)-methylagrimonolide against drug-resistant Candida albicans.

Journal: Bioorganic chemistry

Published: August 21, 2025

Exploration of piperazine-azole hybrids as antifungal agents against drug-resistant Candida albicans.

Exploration of piperazine-azole hybrids as antifungal agents against drug-resistant Candida albicans.

Journal: Bioorganic chemistry

Published: July 24, 2025

(±)-Agrimonolide: Efficient synthesis and treatment of inflammatory bowel disease via JAK1/STAT3 pathway inhibition.

(±)-Agrimonolide: Efficient synthesis and treatment of inflammatory bowel disease via JAK1/STAT3 pathway inhibition.

Journal: Bioorganic & medicinal chemistry

Published: July 07, 2025

New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways.

New 1,2,3-triazole-linked (±)-agrimonolide derivatives as anti-ulcerative colitis agents inhibiting JAK1/STAT3 pathways.

Journal: Molecular diversity

Published: July 04, 2025

Exploration of new azole derivatives containing ethanolamine moiety as anti-UC agents by inhibiting NF-κB/MAPK pathways.

Exploration of new azole derivatives containing ethanolamine moiety as anti-UC agents by inhibiting NF-κB/MAPK pathways.

Journal: Molecular diversity

Published: June 10, 2025

Huatanhuoxue decoction alleviates airway inflammation by regulating IL-17A signaling pathway in obese asthmatic mice.

Huatanhuoxue decoction alleviates airway inflammation by regulating IL-17A signaling pathway in obese asthmatic mice.

Journal: Journal of ethnopharmacology

Published: January 27, 2025

N-Heterocyclic functionalized chalcone derivatives as anti-inflammatory agents for atopic dermatitis treatment by inhibiting JAK1/STAT3 signaling pathway.

N-Heterocyclic functionalized chalcone derivatives as anti-inflammatory agents for atopic dermatitis treatment by inhibiting JAK1/STAT3 signaling pathway.

Journal: Bioorganic chemistry

Published: December 06, 2024

Synthesis and antifungal evaluation of new azole derivatives containing 1,2,3-triazole.

Synthesis and antifungal evaluation of new azole derivatives containing 1,2,3-triazole.

Journal: RSC medicinal chemistry

Published: September 14, 2024

Showing 1-12 of 37

Last Updated: 09/26/2026